LivaNova, a medical technology and innovation company, honors National Epilepsy Awareness Month in the United States this November. The company is working to bring more awareness to epilepsy, the fourth most common neurological disorder impacting more than 65 million people of all ages around the world. As that number continues to rise, there is an increasing need to bring attention to the disorder, share information regarding available treatment options and increase education to break down the stigma associated with epilepsy.
LivaNova has strong partnerships throughout the epilepsy community. In the past year alone, the company has partnered with more than 200 advocacy organizations and professional societies in the U.S., including the American Epilepsy Society, the Epilepsy Foundation, Epilepsy Alliance America, the Danny Did Foundation and the Child Neurology Foundation.
Most recently, LivaNova joined forces with actor Greg Grunberg, one of the most prominent and active advocates within the epilepsy community. His 23-year-old son, Jake, was diagnosed with drug-resistant epilepsy or DRE (where medication alone does not provide adequate seizure control) at just seven years old.
Today, Grunberg’s son Jake is a thriving young adult. In combination with other treatments and lifestyle modifications, his seizures are controlled thanks to the Vagus Nerve Stimulation Therapy (VNS Therapy) System, an FDA-approved treatment for DRE. VNS Therapy has been a constant Jake has relied on for more than 10 years.
LivaNova will kick off Epilepsy Awareness Month with another partnership. The VNS Therapy team will be at Epilepsy Awareness Day at Disneyland November 4 - 6, 2019, along with Greg Grunberg and other patient advocates.